Early Stage Venture Chord Therapeutics Raises Series A of $16000000

About Chord Therapeutics

Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.

Website: Learn more on Chord Therapeutics’s website

Crunchbase: Follow on Crunchbase

Series A – Chord Therapeutics

Amount Raised16000000 USD
Announced Date2020-10-13
Equity Only FundingYes
Organization LocationGeneva, Geneve, Switzerland, Europe
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead InvestorsOmega Funds
Number of Investors1
Number of Partner Investors2

Written by Startup News

Early Stage Venture Priothera Raises Series A of $35438833

Early Stage Venture Casai Raises Series A of $23000000